Teh, Charis E.
The University of Melbourne · Walter and Eliza Hall Institute of Medical Research
3 papers on CoChatORCID 0000-0002-9745-2876
Most cited papers
- Verified
Acquisition of the Recurrent Gly101Val Mutation in BCL2 Confers Resistance to Venetoclax in Patients with Progressive Chronic Lymphocytic Leukemia
Blombery, P., Anderson, M. A., Gong, J.-N., Thijssen, R., Birkinshaw, R. W., Thompson, E. R., Teh, C. E., Nguyen, T., Xu, Z., Flensburg, C., et al. (2019) · Cancer Discovery
Chronic Lymphocytic Leukemia ResearchCell death mechanisms and regulation
Cited by 434
- Verified
A phase Ib dose-escalation and expansion study of the BCL2 inhibitor venetoclax combined with tamoxifen in ER and BCL2-positive metastatic breast cancer
Lok, S. W., Whittle, J. R., Vaillant, F., Teh, C. E., Lo, L. L., Policheni, A. N., Bergin, A. R. T., Desai, J., Ftouni, S., Gandolfo, L. C., et al. (2019) · Cancer Discovery
Advanced Breast Cancer TherapiesBreast Cancer Treatment Studies
Cited by 148
- Verified
Removing unwanted variation with CytofRUV to integrate multiple CyTOF datasets
Trussart, M., Teh, C. E., Tan, T., Leong, L., Gray, D. H., & Speed, T. P. (2020) · eLife
Single-cell and spatial transcriptomicsAdvanced Proteomics Techniques and Applications
Cited by 51
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free